The GiACTA trial: Tocilizumab in giant cell arteritis
Stone et al. Trial of Tocilizumab in Giant-Cell Arteritis. N ...
The MIRRA trial: Mepolizumab (Nucala) or placebo for the treatment of EGPA/Churg-Strauss Syndrome
Wechsler et al. Mepolizumab or Placebo for Eosinophilic Granulomatosis with ...
How do the IL-5 inhibitors Cinqair, Fasenra, and Nucala work?
The IL-5 inhibitors Cinqair (reslizumab), Fasenra (benralizumab), and Nucala (mepolizumab) ...